Elicio Therapeutics, Inc. (ELTX)
1.92
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
1.92
0.00 (0.00%)
After-Hours: 20:00
Elicio Therapeutics Net Income (Quarterly) : -8.217M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.217M |
| March 31, 2026 | -11.82M |
| December 31, 2025 | -7.718M |
| September 30, 2025 | -10.08M |
| June 30, 2025 | -10.56M |
| March 31, 2025 | -11.21M |
| December 31, 2024 | -14.00M |
| September 30, 2024 | -18.84M |
| June 30, 2024 | -7.229M |
| March 31, 2024 | -11.83M |
| December 31, 2023 | -8.949M |
| September 30, 2023 | -10.66M |
| June 30, 2023 | -7.559M |
| March 31, 2023 | -8.029M |
| Date | Value |
|---|---|
| December 31, 2022 | -6.651M |
| September 30, 2022 | -7.198M |
| June 30, 2022 | -7.299M |
| March 31, 2022 | -14.24M |
| December 31, 2021 | 14.89M |
| September 30, 2021 | -15.70M |
| June 30, 2021 | -17.07M |
| March 31, 2021 | -36.69M |
| December 31, 2020 | -28.88M |
| September 30, 2020 | -17.67M |
| June 30, 2020 | -20.34M |
| March 31, 2020 | -13.22M |
| December 31, 2019 | -16.02M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
| Curis, Inc. | -8.581M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 8.217M |
| EPS Diluted (Quarterly) | -0.427 |
| Enterprise Value | 32.72M |
| Earnings Yield | -110.1% |
| Normalized Earnings Yield | -111.46 |